This randomized , double-blind , placebo-controlled clinical study was performed among 48 patients with relapsing-remitting MS. Subjects were randomly assigned to a placebo group ( n = 24 ) or coenzyme Q10 ( CoQ10 ) - supplemented group ( 500 mg/day , n = 24 ) .